ABSTRACT
129
Isolation of methanolic fractions from G. oppositifolius 130 The aerial parts of G. oppositifolius were shade dried (1kg) and were first defatted 131 using petroleum ether (60-80 o C, 3.5L X 3) at room temperature for 48h. The marc was 132 than subjected to extraction using MeOH (3.5L X 3) at room temperature for 48h. The 3.6g), n-BuOH fraction (NBF; 4.1g) and aqueous fraction (AF; 2.3g). All the fractions were 138 stored at 4ºC till further use.
139
Among these four fractions, n-BuOH showed promising antileishmanial activity. 100μg/ml streptomycin sulfate, 25mM HEPES) was used to culture the promastigotes.
155
Axenic amastigote from the log phase culture of promastigotes was prepared as MФs were parasitized with CFSE-tagged (25μM/1×10 6 promastigote in 1ml media 183 for 30min) promastigotes followed by Spergulin-A (10,20,30μg/ml) treatment for 24h. A dose-dependent increase in TNF-α production was monitored in treated (24h) MФs 218 in two sets ( Figure 2B and C) . In first set the lead fraction was applied at the doses of 10, 20, 219 40 and 80μg/ml ( Figure 2B ) and in the second set at the doses of 20, 30, 40 and 50μg/ml and 220 most increments was noticed at 30μg/ml ( Figure 2C ) and selected as the significant dose for 221 this study. and 50μg/ml) of the lead fraction for 24h was monitored by MTT assay ( Figure 2D ). The lead 225 fraction was found safe for this dose range, and survival was about 81.45% even at 50μg/ml.
226
Most increment (5fold) in extracellular NO was noticed for 30μg/ml of the lead fraction 227 ( Figure 2E ). The increase was also significant for most of the doses.
228

Identification and characterization of Spergulin-A
229
Among those six n-BuOH bioactive sub-fractions, fraction 4 have shown most 230 significant upliftment in TNF-α and extracellular NO production. After purification of this 231 fraction by using column chromatography, a white amorphous compound was obtained.
232
Molecular formula C35H58O11S ( Figure 3A) was assigned from the ESI-MS (Supple. 
235
All the spectral data of this compound were found to be in complete agreement with respectively for promastigote and axenic forms even at 100μg/ml. At the lower doses (10, 20 242 and 30μg/ml) the viability reduction was found to be non-significant ( Figure 3B ).
243
After that, the effect of Spergulin-A was evaluated against the MФ internalized 244 parasites ( Figure 3C ). Here, a significant reduction of the parasite was noticed as low as 245 10μg/ml and further increased with the increment of doses ( Figure 3C ). However, above 246 30μg/ml MФ internalized antileishmanial effect of Spergulin-A had reached a plateau, and 247 thus further experiments were mostly conducted with 30μg/ml. Figure 4C .ii) and significantly higher in the treated panel ( Figure   270 4C.iii). The fluorescence intensity of DAF-2DA for NO was also found to be highest for the 271 treated panel (Figure 4D .iii) compared to the control and infected MФs ( Figure 4D.i and ii) . promising one. The fraction was also considered to be safe for the MФs even at 50μg/ml 298 (81.5% viability) having CC 50 well above 100μg/ml.
299
Interested by the initial observations on elevated immunostimulation by the n-BuOH 
